A Longer Tpeak-Tend Interval Is Associated with a Higher Risk of Death: A Meta-Analysis

Cathrin Caroline Braun1, Matthias Daniel Zink2, Sophie Gozdowsky3

  • 1Department of Anesthesiology, Medical Faculty, RWTH Aachen University, Pauwelsstraße 30, 52074 Aachen, Germany.

Insights

The T peak-T end interval, a measure on electrocardiograms (ECG), is significantly linked to all-cause mortality. A prolonged interval indicates a higher risk of death, suggesting its potential as a cardiovascular risk stratification tool.

Area of Science:

  • Cardiology
  • Clinical Electrophysiology
  • Preventive Medicine

Background:

  • Establishing noninvasive cardiovascular risk stratification tools remains a clinical challenge.
  • Previous research indicates a prolonged T peak-T end interval may predict mortality.

Purpose of the Study:

  • To systematically evaluate the association between the T peak-T end interval and mortality outcomes.
  • To assess the prognostic value of the T peak-T end interval in cardiovascular risk stratification.

Main Methods:

  • A meta-analysis of observational studies was conducted.
  • Searched Medline (PubMed), Embase, and Cochrane Library from January 2008 to July 2020.
  • Included 29 studies with 23,114 patients assessing T peak-T end interval and all-cause mortality.

Main Results:

  • All-cause deaths were associated with longer T peak-T end intervals (SMD 0.41).
  • Patients with prolonged T peak-T end intervals had a 2.33-fold higher risk of all-cause death.
  • Heart rate correction did not alter the association, but measurement methods showed variability.

Conclusions:

  • The T peak-T end interval is significantly associated with all-cause mortality.
  • The T peak-T end interval shows potential as a noninvasive prognostic marker.
  • Further research is needed to confirm its clinical utility in risk stratification.

Related Concept Videos

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Hazard Rate01:11

Hazard Rate

The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...